Biotech8 hours ago
NanoPhoria Bioscience Secures €83.5 Million Series A to Advance Heart Failure Therapy
NanoPhoria Bioscience has raised the first tranche of its €83.5 million Series A round, led by Xgen Venture, Sofinnova Partners, and CDP Venture Capital, marking Italy’s...